A glycoengineered antigen exploiting a conserved protein O-glycosylation pathway in the Burkholderia genus for detection of glanders infections
Open Access
- 28 January 2021
- journal article
- research article
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 493-506
Abstract
We recently described a protein O-glycosylation pathway conserved in all species of the Burkholderia genus that results in the synthesis and incorporation of a trisaccharide glycan to membrane-exported proteins. Here, we exploited this system to construct and evaluate a diagnostic tool for glanders. Burkholderia mallei, the causative agent of glanders, is a highly infectious and fatal zoonotic pathogen that infects horses, mules, donkeys, and occasionally humans. A highly sensitive and specific diagnostic tool is crucial for the control, elimination, and eradication of B. mallei infections. We constructed plasmids carrying synthetic genes encoding a modified, previously unannotated Burkholderia glycoprotein containing three glycosylation sequons fused to the cholera toxin B-subunit. The resulting proteins were glycosylated in the B. cenocepacia K56-2 parental strain, but not in glycosylation-deficient mutants, as determined by SDS-PAGE and fluorescent lectin blots. One of these glycoproteins was used as an antigen in ELISA and western blots to screen a panel of serum samples collected from glanders-infected and healthy horses, which were previously investigated by complement fixation test and indirect ELISA based on a semi-purified fraction of B. mallei. We show that ELISA and western blot assays based on our glycoprotein antigen provide 100% specificity, with a sensitivity greater than 88%. The glycoprotein antigen was recognized by serum samples collected from patients infected with B. pseudomallei, B. mallei, B. multivorans, and B. cenocepacia. Our results indicate that protein O-glycosylation in Burkholderia can be exploited as a biomarker for diagnosis of Burkholderia-associated infections.Keywords
All Related Versions
Funding Information
- Medical Research Council Confidence in Concept (CD1617-CIC04)
- National Health and Medical Research Council (APP1100164)
- National Health and Medical Research Council (APP1100164)
- Medical Research Council Canada (CD1617-CIC04)
This publication has 42 references indexed in Scilit:
- Glanders: an overview of infection in humansOrphanet Journal of Rare Diseases, 2013
- Development and validation of a method for purification of mallein for the diagnosis of glanders in equinesBMC Veterinary Research, 2012
- Use of a Recombinant Burkholderia Intracellular Motility A Protein for Immunodiagnosis of GlandersClinical and Vaccine Immunology, 2011
- Use of a Western blot technique for the serodiagnosis of glandersBMC Veterinary Research, 2011
- Mascot-Derived False Positive Peptide Identifications Revealed by Manual Analysis of Tandem Mass SpectraJournal of Proteome Research, 2009
- Prevalence-dependent use of serological tests for diagnosing glanders in horsesBMC Veterinary Research, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Artemis and ACT: viewing, annotating and comparing sequences stored in a relational databaseBioinformatics, 2008
- A Novel Sensor Kinase-Response Regulator Hybrid Controls Biofilm Formation and Type VI Secretion System Activity in Burkholderia cenocepaciaInfection and Immunity, 2008
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007